Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

计划入组 60 人 · 首次发布于 2010 年 12 月 8 日

Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding

计划入组 60 人 · 首次发布于 2010 年 12 月 8 日

Allo-hNHL (FluBuCy)

计划入组 84 人 · 首次发布于 2008 年 11 月 5 日

CD19 (Allogene Therapeutics)

ALLO-316

Allogeneic anti-TNFRSF6 CAR-T (Allogene Therapeutics, Inc)

Allogene Therapeutics

United States

Allozyne, Inc.

United States

Alvogen, Inc.

United States

Allogene Secures Full Control of CAR-T Therapy Following Favorable Arbitration Ruling

Allogene Pauses Cema-Cel Trial Enrollment, Prioritizes Other Programs

Allogene Therapeutics Halts Enrollment in Leukemia Trial Cema-Cel Due to Slow Recruitment